At Vision Expo, the company behind the Heru Prime virtual reality headset for vision care pretesting showcased an upgrade ...

The primary applications of virtual reality in ophthalmology include physician and patient education, diagnostic testing in ...

Axpaxli shows modest advantage over Eylea in trial Retinal specialists may value trial data more than investors, analyst says Ocular plans FDA discussions and marketing application The ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...

ABSTRACT: Objective: To determine the demographic characteristics, incidence trends, and treatment outcomes of Pediatric Traumatic Brain Injury at Bugando Medical Center (BMC). Methods: A ...

Plotting a challenge to Regeneron’s blockbuster Eylea, Ocular Therapeutix has hired “a key architect” of its rival’s launch to head its commercial team. David Robinson has joined Ocular as global ...

Purpose To identify factors associated with visual function and quality of life (QOL) in cosmetic shell (scleral shell) wearers. Methods This nationwide, cross-sectional, multicentre study was ...

Ocular Therapeutix (OCUL) added ~21% in the premarket on Thursday after the French publication La Lettre reported that Sanofi (SNY) is readying an improved takeover offer to acquire the U.S. eye ...

Sanofi is readying an improved takeover offer for Ocular Therapeutix after the company rejected a prior proposal, according to several outlets, citing a report from French publication La Lettre. The ...

Tom Aspinall is due to have surgery in the coming weeks after sustaining an eye injury in October, with the UFC heavyweight champion hitting out at the man who caused the injury. At UFC 321, ...

Tom Aspinall has been diagnosed with a rare condition in both eyes and is not yet clear to return to action as he provided a worrying update on the injury he sustained in his heavyweight title defence ...